Opportunity Information: Apply for CDC RFA DD11 1109
Apply for CDC RFA DD11 1109
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Public Health Surveillance of Deep Vein Thrombosis and Pulmonary Embolism" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on May 31, 2011 and posted on May 31, 2011.
- Applicants must submit their applications by Aug 1, 2011 500pm Eastern Standard Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,800,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Public Health Surveillance of Deep Vein Thrombosis and Pulmonary Embolism" (Funding Opportunity Number: CDC RFA DD11 1109) is a discretionary funding announcement from the Centers for Disease Control and Prevention (CDC) that supports public health surveillance work focused on two serious and related conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). The core aim of the opportunity is to strengthen and expand surveillance activities that help public health agencies and partners understand the burden, patterns, and impacts of these conditions. In practical terms, the CDC frames surveillance as a foundational public health function used to assess overall health status, set and refine public health priorities, evaluate the effectiveness of prevention and control programs, and encourage further research by improving the availability and quality of data.
This funding is offered as a cooperative agreement, meaning awardees should expect substantial involvement from CDC beyond what is typical in a standard grant. Cooperative agreements are generally designed for projects where the federal agency anticipates an active partnership role, such as providing technical guidance, helping coordinate across sites, supporting methodological consistency, or facilitating dissemination of findings. The funding activity category is Health, and the CFDA number listed is 93.184 (Disabilities Prevention), which signals the program area within federal assistance listings that this opportunity aligns with.
The announcement anticipated making three awards in total. The estimated total funding amount is $1,800,000, with an expected award range (floor to ceiling) of $200,000 to $400,000 per award. The presence of a defined floor and ceiling suggests projects were expected to be scoped to a mid-sized surveillance effort, large enough to produce meaningful population-level information while still fitting within a bounded budget typical of pilot or multi-site surveillance initiatives. There is no cost sharing or matching requirement, so applicants were not required to provide non-federal matching funds as a condition of eligibility.
Eligibility is described as "Unrestricted," meaning it was open broadly to any type of entity, subject to any further clarification that may have appeared in the full announcement. In government grant language, this usually implies a wide applicant pool that can include, depending on the full text, state and local health departments, tribes or tribal organizations, universities, hospitals or health systems, nonprofit organizations, and potentially certain for-profit entities, provided they meet the specific eligibility conditions and can carry out the required public health surveillance functions. The listing notes that any finer points about eligibility would be contained in the full announcement, referenced through an Additional Information link that is no longer active.
Key timing details indicate this opportunity was posted and created on May 31, 2011. The original and current closing dates were the same: August 1, 2011 at 5:00 pm Eastern Standard Time, and the archive date was August 31, 2011. Those dates reflect a relatively standard application window for a CDC discretionary opportunity at the time, giving applicants roughly two months to develop a surveillance proposal, assemble partnerships and data access plans, and submit required federal application materials.
The subject matter focus, DVT and PE, fits within a larger public health concern around venous thromboembolism (VTE), where DVT refers to a blood clot typically forming in a deep vein (often in the leg) and PE refers to a potentially life-threatening event that occurs when a clot (or part of it) travels to and blocks arteries in the lungs. Surveillance for these conditions can be challenging because events may be diagnosed in different settings (inpatient, emergency, outpatient), coding and diagnostic practices can vary, and cases may be recurrent or linked to risk factors such as surgery, hospitalization, immobility, cancer, pregnancy, or certain medications. A surveillance-focused cooperative agreement of this kind typically supports efforts to improve case finding, define consistent case definitions, validate administrative or clinical data sources, measure incidence and outcomes, and identify disparities across populations or regions. The CDC description emphasizes the broad public health value of surveillance: it is used not only to count cases, but also to guide prevention priorities, evaluate interventions and systems of care, and create a stronger evidence base for future research and policy decisions.
For applicants needing access to the complete announcement at the time, the notice directed them to use the "Full Announcement" tab rather than the inactive link. It also provided a point of contact for technical access issues through the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), with a phone number (770-488-2700) for general submission inquiries. This indicates the CDC expected standard electronic submission procedures, with support available for applicants who encountered barriers retrieving the full application package or understanding submission mechanics.
FAQs: Public Health Surveillance of Deep Vein Thrombosis and Pulmonary Embolism (CDC RFA DD11-1109)
What is the title of this grant opportunity?
The opportunity is titled "Public Health Surveillance of Deep Vein Thrombosis and Pulmonary Embolism".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA DD11 1109.
Which federal agency is offering this funding?
This is a discretionary funding announcement from the Centers for Disease Control and Prevention (CDC).
What is the primary purpose of this opportunity?
The core purpose is to strengthen and expand public health surveillance focused on deep vein thrombosis (DVT) and pulmonary embolism (PE), to better understand the burden, patterns, and impacts of these conditions.
What does CDC mean by "public health surveillance" in this opportunity?
In this context, surveillance is presented as a foundational public health function used to assess overall health status, set and refine public health priorities, evaluate prevention and control programs, and encourage additional research by improving the availability and quality of data.
What conditions are the focus of the surveillance work?
The surveillance focus is on two related conditions:
- Deep vein thrombosis (DVT): a blood clot forming in a deep vein (often in the leg).
- Pulmonary embolism (PE): a potentially life-threatening event where a clot travels to and blocks arteries in the lungs.
How are DVT and PE related to venous thromboembolism (VTE)?
DVT and PE are described as part of a broader public health concern around venous thromboembolism (VTE), where DVT can lead to PE if a clot (or part of it) travels to the lungs.
What type of funding mechanism is used?
The funding is offered as a cooperative agreement.
What does it mean that this is a cooperative agreement?
A cooperative agreement means awardees should expect substantial CDC involvement beyond what is typical in a standard grant. The description indicates CDC involvement may include technical guidance, coordination across sites, supporting methodological consistency, and helping facilitate dissemination of findings.
What is the funding activity category?
The funding activity category is Health.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.184 (Disabilities Prevention).
How many awards were anticipated?
The announcement anticipated making three awards in total.
What was the estimated total funding amount?
The estimated total funding amount is $1,800,000.
What is the expected award amount per recipient?
The expected award range is $200,000 to $400,000 per award (floor to ceiling).
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
Who was eligible to apply?
Eligibility is described as "Unrestricted", meaning it was broadly open to any type of entity, subject to any further details that would have been included in the full announcement.
What does "Unrestricted" eligibility generally imply?
Based on the wording provided, "Unrestricted" generally implies a wide applicant pool that can include entities such as state and local health departments, tribes or tribal organizations, universities, hospitals or health systems, nonprofit organizations, and potentially certain for-profit entities, as long as they meet any specific eligibility conditions in the full announcement and can carry out the surveillance-related work.
When was the opportunity posted?
The opportunity was posted (and created) on May 31, 2011.
What was the application deadline?
The original and current closing date was August 1, 2011 at 5:00 pm Eastern Standard Time.
When was the opportunity archived?
The archive date was August 31, 2011.
How long was the application window?
Based on the posted date (May 31, 2011) and closing date (August 1, 2011), applicants had roughly about two months to prepare and submit an application.
What kinds of surveillance challenges does this opportunity recognize for DVT and PE?
The description notes that surveillance can be challenging because DVT and PE events may be diagnosed in different settings (inpatient, emergency, outpatient), coding and diagnostic practices can vary, and cases may be recurrent or linked to a range of risk factors.
What risk factors are mentioned as relevant to DVT/PE?
The opportunity description mentions several examples of risk factors linked to DVT/PE, including surgery, hospitalization, immobility, cancer, pregnancy, and certain medications.
What kinds of activities might a surveillance-focused cooperative agreement support?
The description indicates this type of cooperative agreement typically supports efforts such as improving case finding, defining consistent case definitions, validating administrative or clinical data sources, measuring incidence and outcomes, and identifying disparities across populations or regions.
How does CDC describe the public health value of surveillance in this program?
CDC emphasizes that surveillance is used not only to count cases, but also to guide prevention priorities, evaluate interventions and systems of care, and create a stronger evidence base for future research and policy decisions.
Where were applicants instructed to find the complete announcement?
The notice directed applicants to use the "Full Announcement" tab rather than an Additional Information link that was no longer active.
Who could applicants contact for technical access or submission questions?
For technical access issues, the announcement listed the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
What phone number was provided for general submission inquiries?
The phone number provided for general submission inquiries was 770-488-2700.
What does the award range suggest about the expected size or scope of projects?
The presence of a defined floor and ceiling ($200,000 to $400,000) suggests projects were expected to be scoped as mid-sized surveillance efforts, intended to produce meaningful population-level information while staying within a bounded budget.
Browse more opportunities from the same category: Health
Next opportunity: FY11 Region 04 Wetland Program Development Grants
Previous opportunity: Intermountain West Joint Venture Sage Grouse Initiative Strategic Watershed Action Team
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD11 1109
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD11 1109) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing Support and Educational Awareness for Young (45) Breast Cancer Survivors in the United States Apply for CDC RFA DP11 1111 Funding Number: CDC RFA DP11 1111 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $230,000 |
| Affordable Care Act (ACA) Maternal, Infant and Early Childhood Home Visiting Program Apply for HRSA 11 179 Funding Number: HRSA 11 179 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition NIMHD Revision Applications to Support Environmental Health Disparities Research (P60) Apply for RFA MD 11 008 Funding Number: RFA MD 11 008 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Limited Competition NIMHD Revision Applications to Support Environmental Health Disparities Research (P20) Apply for RFA MD 11 007 Funding Number: RFA MD 11 007 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Reducing the Impact of Hypertension in Low and Middle Income Countries (U01) Apply for RFA HL 12 027 Funding Number: RFA HL 12 027 Agency: National Institutes of Health Category: Health Funding Amount: $230,000 |
| FY11 Minority Youth Tobacco Elimination Project (MYTEP) Apply for MP MPC 11 002 Funding Number: MP MPC 11 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $250,000 |
| Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities Apply for HHS 2011 IHS EPI 0001 Funding Number: HHS 2011 IHS EPI 0001 Agency: Indian Health Service Category: Health Funding Amount: $1,000,000 |
| Fetal Alcohol Spectrum Disorders Regional Training Centers Apply for CDC RFA DD11 1107 Funding Number: CDC RFA DD11 1107 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Enhancing Capacity for Environmental and Public Health Surveillance of Unregulated Drinking Water Apply for CDC RFA EH11 1108 Funding Number: CDC RFA EH11 1108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $70,000 |
| State Based Perinatal Quality Collaboratives Apply for CDC RFA DP11 1110 Funding Number: CDC RFA DP11 1110 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| National Organizations for State and Local Officials (NOSLO) Apply for HRSA 11 169 Funding Number: HRSA 11 169 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Scaling up HIV/AIDs Prevention Activities for Most at Risk Populations, People living with HIV/AIDs and Orphans and Vulnerable Children in Ghana Apply for APS 641 11 000003 Funding Number: APS 641 11 000003 Agency: Ghana USAID Accra Category: Health Funding Amount: $1,200,000 |
| Enhancing Breast Cancer Genomic Practices through Education, Surveillance, and Policy Apply for CDC RFA DP11 1114 Funding Number: CDC RFA DP11 1114 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| FY11 United States Mexico Border Health Commission Border Health Improvement Initiative Apply for GH GHS 11 001 Funding Number: GH GHS 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,300,000 |
| Prevention and Public Health Fund Coordinated Chronic Disease Prevention and Health Promotion Program Apply for CDC RFA DP09 9010301PPHF11 Funding Number: CDC RFA DP09 9010301PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Prevention and Public Health Fund Pacific Islands Coordinated Chronic Disease Prevention and Health Promotion Program Apply for CDC RFA DP09 9020303PPHF11 Funding Number: CDC RFA DP09 9020303PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Spinal Muscular Atrophy (SMA) Biomarker Study (U01) Apply for RFA NS 12 004 Funding Number: RFA NS 12 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP HTM) (U19) Apply for RFA AI 11 031 Funding Number: RFA AI 11 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Healthy Women of Ukraine Program (HWUP) Apply for RFA 121 11 000002 Funding Number: RFA 121 11 000002 Agency: Ukraine USAID Kiev Category: Health Funding Amount: $8,200,000 |
| Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43) Apply for RFA AR 12 006 Funding Number: RFA AR 12 006 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD11 1109", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.